"The Ted & Margaret Jorgensen Cancer Center is a multidisciplinary clinic that also includes gynecologic oncology, Presbyterian MD Anderson radiation oncology, breast surgery, surgical oncology, and supportive care services. The clinic is located on the west side of the hospital with its own convenient parking and clinic entrance. A department of Presbyterian Hospital."

During the past decade, Presbyterian Rust Medical Center/Jorgensen Cancer Center conducted 50 clinical trials. In the 10-year time frame, 50 clinical trials started and 7 clinical trials were completed, i.e. on average, 14% percent of trials that started reached the finish line to date. In the past 5 years, 22 clinical trials started and 7 clinical trials were completed. i.e. 31.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Presbyterian Rust Medical Center/Jorgensen Cancer Center" #1 sponsor was "National Cancer Institute (NCI)" with 23 trials, followed by "SWOG Cancer Research Network" with 12 trials sponsored, "Alliance for Clinical Trials in Oncology" with 8 trials sponsored, "NRG Oncology" with 5 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 5 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Presbyterian Rust Medical Center/Jorgensen Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 29 trials as a collaborator, "NRG Oncology" with 7 trials as a collaborator, "Canadian Cancer Trials Group" with 4 trials as a collaborator, "Bayer" with 1 trials as a collaborator and "Cancer Prevention Pharmaceuticals, Inc." with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Presbyterian Rust Medical Center/Jorgensen Cancer Center" are "Stage IV Lung Cancer AJCC v8" (6 trials), "Stage IVA Lung Cancer AJCC v8" (6 trials), "Stage IVB Lung Cancer AJCC v8" (6 trials), "Invasive Breast Carcinoma" (5 trials) and "Recurrent Lung Non-Small Cell Carcinoma" (4 trials). Many other conditions were trialed in "Presbyterian Rust Medical Center/Jorgensen Cancer Center" in a lesser frequency.

Most popular intervention types in "Presbyterian Rust Medical Center/Jorgensen Cancer Center" are "Drug" (42 trials), "Other" (30 trials), "Biological" (23 trials), "Procedure" (20 trials) and "Radiation" (7 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (18 trials), "Computed Tomography" (13 trials), "Biospecimen Collection" (11 trials), "Questionnaire Administration" (11 trials) and "Nivolumab" (9 trials). Other intervention names were less common.

The vast majority of trials in "Presbyterian Rust Medical Center/Jorgensen Cancer Center" are 39 trials for "All" genders, 11 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Presbyterian Rust Medical Center/Jorgensen Cancer Center". undefined are not yet recruiting, 20 are recruiting, 28 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Presbyterian Rust Medical Center/Jorgensen Cancer Center, 3 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Presbyterian Rust Medical Center/Jorgensen Cancer Center, 1 "Phase 1" clinical trials were conducted, 24 "Phase 2" clinical trials and 34 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".